...
首页> 外文期刊>Physiological Research >Diaphorase can metabolize some vasorelaxants to NO and eliminate NO scavenging effect of 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO)
【24h】

Diaphorase can metabolize some vasorelaxants to NO and eliminate NO scavenging effect of 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO)

机译:心肌黄递酶可以将某些血管舒张剂代谢为NO,并消除2-苯基-4,4,5,5-四甲基咪唑啉-1-氧基-3-氧化物(PTIO)的NO清除作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Diaphorase was studied as a possible oxidoreductase participating in NO production from some vasorelaxants. In the presence of NADH or NADPH, diaphorase can convert selected NO donors. glycerol trinitrate, (GTN) and formaldoxime (FAL) to nitrites and nitrates with NO as an intermediate. This activity of diaphorase was inhibited by diphenyleneiodonium (DPI) (inhibitor of some NADPH-dependent flavoprotein oxidoreductases), while it remained uninhibited by NG-nitro-L-arginine methyl ester (inhibitor of NO synthase) 7-Ethoxyresorufin (inhibitor of cytochrome P-450 1A1 and cytochrome P-450 NADPH-dependent reductase) inhibited the conversion of GTN only. Existence of NO as an intermediate of the reaction was supported by results of electron paramagnetic resonance spectroscopy. In addition to its ability to affect the above mentioned NO donors, diaphorase was able to reduce 2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide (PTIO) and thus to eliminate its NO scavenging effect. This activity of diaphorase could also be inhibited by DPI. The reaction of diaphorase with GTN and PTIO was not affected by superoxide dismutase (SOD) or catalase. Reaction of FAL with diaphorase was lowered with SOD by 38% indicating the partial participation of superoxide anion probably generated by the reaction of diaphorase with NADH or NADPH. Catalase had no effect. Diaphorase could apparently be one of the enzymes participating in the metabolism of studied NO donors to NO. The easy reduction and consequent elimination of PTIO by diaphorase could affect its use as an NO scavenger in biological tissues.
机译:心肌黄递酶是一种可能的氧化还原酶,参与某些血管舒张剂的NO生成。在存在NADH或NADPH的情况下,心肌黄酶可以转化选定的NO供体。三硝酸甘油酯(GTN)和福尔多肟(FAL)为亚硝酸盐和硝酸盐,其中NO为中间体。心肌黄递酶的这种活性被二苯撑碘鎓(DPI)(某些NADPH依赖的黄素蛋白氧化还原酶的抑制剂)抑制,而未被NG-硝基-L-精氨酸甲酯(NO合酶的抑制剂)抑制,而7-乙氧基间苯二酚(细胞色素P的抑制剂)被抑制。 -450 1A1和细胞色素P-450 NADPH依赖性还原酶)仅抑制GTN的转化。电子顺磁共振波谱的结果支持了NO作为反应中间体的存在。心肌黄酶除了具有影响上述NO供体的能力外,还能够还原2-苯基-4,4,5,5,-四甲基咪唑啉-1-氧基-3-氧化物(PTIO),从而消除其NO清除能力。影响。心肌黄递酶的这种活性也可以被DPI抑制。心肌黄递酶与GTN和PTIO的反应不受超氧化物歧化酶(SOD)或过氧化氢酶的影响。 FAL与心肌黄酶的反应与SOD相比降低了38%,这表明部分过氧化物阴离子可能是由心肌黄酶与NADH或NADPH反应产生的。过氧化氢酶没有作用。心肌黄递酶显然是参与研究的NO供体向NO代谢的酶之一。心肌黄递酶容易还原并随后消除PTIO,可能会影响其在生物组织中作为NO清除剂的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号